Latest news
Loading news…
Transcenta
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Huangpu, Shanghai, China Founded 2019 101-250 employees For Profit
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Monthly Visits
Available in Pro Contacts
28
Ticker
6628
HKG - Hong Kong Stock Exchange
Patents
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- 6628
- Exchange
- HKG - Hong Kong Stock Exchange
- IPO date
- Sep 29, 2021
- Raised at IPO
- $70M
- Valuation at IPO
- $707M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 32
- Patents granted
- 0
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $612K
Company Info
- Founded
- 2019
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 32
- HQ
- Huangpu, Shanghai, China
- Region
- Asia-Pacific (APAC)
- Exit date
- Sep 29, 2021
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- -1.1
- Trend (90d)
- -2.5
- Last leadership hire
- Mar 30, 2026
Acquisitions by Transcenta
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Transcenta
Head of Global Partnerships
Founder, Chairman and CEO
Senior Vice President of Capital Markets, Investor Relations and Corporate Communications
Executive Vice President, Global Medicine Development and Chief Medical Officer
28
professional contacts at Transcenta
Contact execs at Transcenta →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Transcenta
Loading news…
FAQs about Transcenta
People who checked this page also checked these
Sectors Transcenta invests & acquires in
Browse the full Acquirezy directory.